Lumeris is a company that partners with health systems and physician groups, providing technology, advanced risk management, and value-based care capabilities. Their solutions aim to achieve superior quality metrics, enhanced patient experience, physician satisfaction, and reductions in total cost of care across various populations, including Medicare Advantage, traditional Medicare, Medicaid, and commercial. As of March 2024, Lumeris partnerships manage over USD 13 billion of medical spend nationwide.
Lumeris offers an actionable data platform and proven population health capabilities. Their solutions integrate cutting-edge technology, advanced analytics, streamlined automation, and aligned human processes to drive clinical impact, program performance, team member engagement, and fulfillment. This optimizes value-based efforts across healthcare networks. Lumeris' technology and expertise have played a pivotal role in enhancing value-based performance for their partners.
Lumeris operates Essence healthcare, a wholly-owned Medicare Advantage plan that has received Medicare's highest Overall Plan Rating of five out of five stars for three consecutive years (2022, 2023, 2024). In January 2023, Essence healthcare expanded into five new states and 44 new counties, marking a 223% increase in county coverage within a year.
In November 2022, Lumeris launched Tribus, a value-based care accelerator for practices to convert from fee-for-service to value-based care using a community-based model. Under the guidance of Dr. Chuck Willey, a practicing physician, Tribus offers physician-to-physician training and mentorship.
In November 2023, Lumeris entered into a long-term partnership with NorthShore—Edward-Elmhurst Health to accelerate value-based care delivery for 440,000 patients across all populations. This payer-agnostic partnership aims to enable care coordination, improve clinical outcomes, enhance patient and provider experience, and manage healthcare costs.
In April 2024, Lumeris secured USD 100 million in equity capital funding led by Deerfield Management, with participation from Endeavor Health, BlueCross BlueShield Venture Partners, Sandbox Industries, Kleiner Perkins, and JDLinx. The funds will support the expansion of Lumeris' provider partnerships.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.